|
FAM118B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.63239999999965E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.763300E-04 |
| Normal-vs-Stage2 |
2.986200E-02 |
| Normal-vs-Stage3 |
3.70179999999998E-05 |
| Normal-vs-Stage4 |
1.620160E-01 |
| Stage1-vs-Stage2 |
9.532000E-01 |
| Stage1-vs-Stage3 |
1.225000E-01 |
| Stage1-vs-Stage4 |
5.229800E-01 |
| Stage2-vs-Stage3 |
2.761200E-01 |
| Stage2-vs-Stage4 |
6.324400E-01 |
| Stage3-vs-Stage4 |
1.198210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.95240000000685E-05 |
| Normal-vs-AfricanAmerican |
3.110400E-02 |
| Normal-vs-Asian |
9.365600E-01 |
| Caucasian-vs-AfricanAmerican |
8.723000E-01 |
| Caucasian-vs-Asian |
3.969200E-01 |
| AfricanAmerican-vs-Asian |
4.558400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.41309999993567E-07 |
| Normal-vs-Female |
1.029770E-01 |
| Male-vs-Female |
1.472450E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.035270E-03 |
| Normal-vs-Age(41-60Yrs) |
3.034000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.544520E-03 |
| Normal-vs-Age(81-100Yrs) |
2.748800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.399840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.111600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.218800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.463800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.208000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.706400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.473400E-01 |
| Normal-vs-Grade 2 |
1.69059999999277E-06 |
| Normal-vs-Grade 3 |
8.043700E-04 |
| Normal-vs-Grade 4 |
5.468200E-01 |
| Grade 1-vs-Grade 2 |
4.426000E-01 |
| Grade 1-vs-Grade 3 |
7.238000E-01 |
| Grade 1-vs-Grade 4 |
7.307000E-01 |
| Grade 2-vs-Grade 3 |
4.125400E-01 |
| Grade 2-vs-Grade 4 |
6.017700E-02 |
| Grade 3-vs-Grade 4 |
1.711580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.393070E-04 |
| Normal-vs-ccB subtype |
1.582430E-02 |
| ccA subtype-vs-ccB subtype |
4.330600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.935200E-03 |
| Normal-vs-N1 |
6.476000E-01 |
| N0-vs-N1 |
6.150800E-01 |
|
|
